---
title: "Capreomycin - Pulmonary tuberculosis"
sidebar: mydoc_sidebar
permalink: db00314-mesh-d014397-1.html
toc: false 
---


Path ID: `DB00314_MESH_D014397_1`
{% include image.html url="images/db00314-mesh-d014397-1.png" file="db00314-mesh-d014397-1.png" alt="db00314-mesh-d014397-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D002207 | Capreomycin | Drug |
| GO:0005840 | Ribosome | CellularComponent |
| GO:0006412 | Translation | BiologicalProcess |
| NCBITaxon:1773 | Mycobacterium tuberculosis | OrganismTaxon |
| MESH:D014397 | Pulmonary tuberculosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Capreomycin | DECREASES ACTIVITY OF | Ribosome |
| Ribosome | PARTICIPATES IN | Translation |
| Translation | IN TAXON | Mycobacterium Tuberculosis |
| Mycobacterium Tuberculosis | CAUSES | Pulmonary Tuberculosis |
|---------|-----------|---------|

Comment: Capreomycin is a member of the aminoglycoside family of antibiotics, but little is known about capreomycin's exact mechanism of action. Capreomycin is used in the treatment of tuberculosis in combination with other drugs.

Reference: 
  - [https://go.drugbank.com/drugs/DB00314#BE0009727](https://go.drugbank.com/drugs/DB00314#BE0009727)
